Skip to main contentSkip to navigation
Sirius Investors
Amgen Inc.

Amgen Inc.

AMGN
NASDAQHealthcare

Revenue Analysis - AMGN

Comprehensive quarterly and annual revenue breakdown by product lines and geographic regions to identify growth drivers and market opportunities.

AMGN Corporation

Annual

Revenue by Product Line

Latest quarterly revenue breakdown by product segments

Quarterly Product Revenue

Product Revenue Details

Detailed breakdown of revenue by product line

Other Products

0.0% of total revenue

$2.1B

Prolia

0.0% of total revenue

$1.1B

Otezla

0.0% of total revenue

$625.0M

EVENITY

0.0% of total revenue

$599.0M

ENBREL

0.0% of total revenue

$532.0M

Product and Service, Other

0.0% of total revenue

$499.0M

TEZSPIRE

0.0% of total revenue

$474.0M

TEPEZZA

0.0% of total revenue

$457.0M

XGEVA

0.0% of total revenue

$447.0M

KRYSTEXXA

0.0% of total revenue

$435.0M

BLINCYTO

0.0% of total revenue

$413.0M

Nplate

0.0% of total revenue

$385.0M

Aranesp

0.0% of total revenue

$333.0M

Vectibix

0.0% of total revenue

$319.0M

Historical Revenue Data

Quarterly product revenue breakdown over time (Last 6 records)

Date
Aranesp
BLINCYTO
ENBREL
EVENITY
KRYSTEXXA
Kyprolis
Nplate
Otezla
Other Products
Product and Service, Other
Prolia
Repatha (evolocumab)
TEPEZZA
TEZSPIRE
Vectibix
XGEVA
12/31/2025$333.0M$413.0M$532.0M$599.0M$435.0M$0$385.0M$625.0M$2.1B$499.0M$1.1B$0$457.0M$474.0M$319.0M$447.0M
9/30/2025$357.0M$392.0M$580.0M$541.0M$320.0M$359.0M$457.0M$585.0M$1.9B$420.0M$1.1B$794.0M$560.0M$377.0M$284.0M$539.0M
6/30/2025$359.0M$384.0M$604.0M$518.0M$349.0M$378.0M$369.0M$618.0M$1.7B$408.0M$1.1B$696.0M$505.0M$342.0M$305.0M$532.0M
3/31/2025$340.0M$370.0M$510.0M$442.0M$236.0M$324.0M$313.0M$437.0M$1.6B$276.0M$1.1B$656.0M$381.0M$285.0M$267.0M$566.0M
12/31/2024$308.0M$381.0M$1.0B$431.0M$346.0M$372.0M$337.0M$624.0M$4.3B$1.0B$1.2B$606.0M$460.0M$296.0M$246.0M$561.0M
9/30/2024$337.0M$327.0M$825.0M$399.0M$310.0M$378.0M$456.0M$564.0M$1.4B$352.0M$1.0B$567.0M$488.0M$269.0M$282.0M$541.0M

Revenue Trend Analysis

Analysis of major growing and declining segments based on recent revenue data

Product Segments

Growing Segments
KRYSTEXXA+35.9%
TEZSPIRE+25.7%
Product and Service, Other+18.8%
Declining Segments
TEPEZZA-18.4%
XGEVA-17.1%
Nplate-15.8%

Geographic Regions

Stable Segments
UNITED STATES0.0%
Non-US0.0%

Earnings Reports

Want to see how AMGN's earnings relate to revenue? View quarterly earnings results, EPS history, and earnings surprises to understand the company's profitability.

View Earnings Reports